Skip to main content

Table 2 Intraoperative characteristics stratified by treatment assignment, mean (SD)

From: Factor VIII inhibitor bypass activity (FEIBA) for the reduction of transfusion in cardiac surgery: a randomized, double-blind, placebo-controlled, pilot trial

  FEIBA
n = 6
Placebo
n = 6
Cardiopulmonary bypass duration, min 276 (111) 170 (53)
Aortic cross-clamp time, min 159 (75) 123 (51)
Lowest temperature during CPB, °C 25 (4) 25 (4)
Deep hypothermic cardiac arrest, n (%) 5 (83) 3 (50)
Deep hypothermic cardiac arrest duration, min 93 (26) 24 (5)
FEIBA study drug dose, IU, mean (SD) 1902 (499) 0
Open-label FEIBA, n (%) 2 (33) 1 (17)
 Dose, IU, mean (SD; n1 = 2; n2 = 1) 3772 (1002) 1840 (--)
 Dose, IU, mean (SD; n1 = 6; n2 = 6) 1241 (2024) 307 (751)
  1. FEIBA, factor eight inhibitor bypass activity; CPB, cardiopulmonary bypass